TGFB1 and cancer: TAMs also contribute to the phenotypic switch of fibroblasts into cancer associated fibroblasts (CAFs), and in turn activate multiple pathways specifically TGFβ pathway that leads to inflammation and immune suppression, and the associated chemo-resistance, recurrence and poor prognosis [118, 119].